|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 224.50 SEK | +1.04% |
|
+4.91% | +6.96% |
| 01-12 | Morgan Stanley Raises Price Target for Epiroc to 212 Kronor (200), Reiterates Equal Weight - BN | FW |
| 01-12 | Citigroup Raises Epiroc Target Price to 252 Kronor (234), Reiterates Buy - BN | FW |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11.23 | 12.04 | 12.41 | 12.73 | 10.03 | |||||
Return on Total Capital | 14.64 | 16.16 | 17.26 | 17.26 | 13.05 | |||||
Return On Equity % | 23.24 | 28.55 | 28.37 | 26.75 | 21.78 | |||||
Return on Common Equity | 23.24 | 28.56 | 28.59 | 27.01 | 21.94 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 37.94 | 38.98 | 38.27 | 38.36 | 36.08 | |||||
SG&A Margin | 13.99 | 13.86 | 13.34 | 13.33 | 13.75 | |||||
EBITDA Margin % | 23.95 | 25.01 | 24.65 | 24.69 | 22.29 | |||||
EBITA Margin % | 21.46 | 22.88 | 22.65 | 22.79 | 20.19 | |||||
EBIT Margin % | 21.12 | 22.46 | 22.05 | 21.86 | 19.1 | |||||
Income From Continuing Operations Margin % | 14.98 | 17.83 | 16.93 | 15.67 | 13.77 | |||||
Net Income Margin % | 14.95 | 17.8 | 16.9 | 15.63 | 13.73 | |||||
Net Avail. For Common Margin % | 14.95 | 17.8 | 16.9 | 15.63 | 13.73 | |||||
Normalized Net Income Margin | 12.25 | 14.11 | 13.53 | 12.27 | 10.98 | |||||
Levered Free Cash Flow Margin | 22.78 | 13.35 | 4.39 | 7.63 | 8.96 | |||||
Unlevered Free Cash Flow Margin | 23.21 | 13.64 | 4.84 | 8.5 | 10.26 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.85 | 0.86 | 0.9 | 0.93 | 0.84 | |||||
Fixed Assets Turnover | 6.58 | 7.2 | 7.79 | 8.32 | 7.44 | |||||
Receivables Turnover (Average Receivables) | 5.25 | 5.82 | 5.76 | 5.84 | 5.41 | |||||
Inventory Turnover (Average Inventory) | 2.31 | 2.33 | 2.13 | 2.08 | 2.14 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 3.64 | 2.65 | 2.21 | 2.42 | 2.48 | |||||
Quick Ratio | 2.57 | 1.64 | 1.16 | 1.24 | 1.36 | |||||
Operating Cash Flow to Current Liabilities | 0.94 | 0.61 | 0.32 | 0.42 | 0.57 | |||||
Days Sales Outstanding (Average Receivables) | 69.67 | 62.75 | 63.42 | 62.45 | 67.67 | |||||
Days Outstanding Inventory (Average Inventory) | 158.67 | 156.84 | 171.38 | 175.12 | 170.76 | |||||
Average Days Payable Outstanding | 67.22 | 61.34 | 60.67 | 57.45 | 51.91 | |||||
Cash Conversion Cycle (Average Days) | 161.12 | 158.25 | 174.13 | 180.11 | 186.52 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 42.78 | 35.64 | 32.46 | 37.56 | 50.99 | |||||
Total Debt / Total Capital | 29.96 | 26.28 | 24.5 | 27.3 | 33.77 | |||||
LT Debt/Equity | 39.98 | 33.21 | 26.49 | 31.77 | 45.42 | |||||
Long-Term Debt / Total Capital | 28 | 24.48 | 20 | 23.1 | 30.08 | |||||
Total Liabilities / Total Assets | 45.91 | 46.93 | 45.76 | 45.1 | 48.34 | |||||
EBIT / Interest Expense | 30.63 | 48.39 | 30.61 | 15.82 | 9.22 | |||||
EBITDA / Interest Expense | 36.6 | 56.4 | 35.64 | 18.61 | 11.32 | |||||
(EBITDA - Capex) / Interest Expense | 34.57 | 53.74 | 33.96 | 17.35 | 10.64 | |||||
Total Debt / EBITDA | 1.11 | 0.89 | 0.85 | 0.9 | 1.48 | |||||
Net Debt / EBITDA | -0.54 | -0.15 | 0.28 | 0.49 | 1 | |||||
Total Debt / (EBITDA - Capex) | 1.18 | 0.93 | 0.89 | 0.97 | 1.57 | |||||
Net Debt / (EBITDA - Capex) | -0.57 | -0.16 | 0.29 | 0.52 | 1.06 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -11.57 | 9.75 | 25.35 | 21.43 | 5.4 | |||||
Gross Profit, 1 Yr. Growth % | -10.54 | 12.76 | 23.08 | 21.7 | -0.86 | |||||
EBITDA, 1 Yr. Growth % | -7.88 | 14.61 | 23.22 | 22.15 | -4.84 | |||||
EBITA, 1 Yr. Growth % | -7.31 | 17.02 | 23.82 | 22.71 | -6.62 | |||||
EBIT, 1 Yr. Growth % | -7.44 | 16.73 | 22.75 | 20.95 | -7.92 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -8.06 | 30.67 | 18.98 | 12.45 | -7.42 | |||||
Net Income, 1 Yr. Growth % | -8.09 | 30.73 | 18.97 | 12.31 | -7.42 | |||||
Normalized Net Income, 1 Yr. Growth % | -10.97 | 26.41 | 19.87 | 10.62 | -5.69 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -8.38 | 30.36 | 19.01 | 12.37 | -7.44 | |||||
Accounts Receivable, 1 Yr. Growth % | -17.54 | 19.32 | 32.85 | 9.58 | 17.85 | |||||
Inventory, 1 Yr. Growth % | -15.02 | 32.82 | 42.86 | 10.63 | 2.37 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -11.62 | 13.92 | 17.41 | 10.56 | 24.44 | |||||
Total Assets, 1 Yr. Growth % | 6.94 | 10.7 | 27.16 | 9.72 | 23.32 | |||||
Tangible Book Value, 1 Yr. Growth % | 5.65 | -5.55 | 7.84 | 5.17 | -15.72 | |||||
Common Equity, 1 Yr. Growth % | 4.09 | 8.59 | 28.34 | 11.51 | 16.12 | |||||
Cash From Operations, 1 Yr. Growth % | 15.3 | -8.72 | -26.94 | 28.52 | 46.44 | |||||
Capital Expenditures, 1 Yr. Growth % | 4.32 | -3.55 | 22.7 | 74 | -14.75 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 51.32 | -35.67 | -58.75 | 114.37 | 25.49 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 48.14 | -35.5 | -55.49 | 116.13 | 28.82 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.17 | 20 | 13.33 | 11.76 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -2.87 | -1.48 | 17.29 | 23.37 | 13.13 | |||||
Gross Profit, 2 Yr. CAGR % | -0.95 | 0.44 | 17.81 | 22.39 | 9.84 | |||||
EBITDA, 2 Yr. CAGR % | -1.21 | 2.75 | 18.97 | 22.43 | 7.81 | |||||
EBITA, 2 Yr. CAGR % | -0.99 | 4.15 | 20.53 | 22.99 | 7.05 | |||||
EBIT, 2 Yr. CAGR % | -1.08 | 3.94 | 19.86 | 21.57 | 5.53 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -0.25 | 9.61 | 24.69 | 15.67 | 2.03 | |||||
Net Income, 2 Yr. CAGR % | -0.29 | 9.62 | 24.71 | 15.59 | 1.97 | |||||
Normalized Net Income, 2 Yr. CAGR % | -2.93 | 6.09 | 23.26 | 14.89 | 2.14 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -0.11 | 9.28 | 24.55 | 15.64 | 1.98 | |||||
Accounts Receivable, 2 Yr. CAGR % | -13.89 | -0.81 | 25.9 | 20.66 | 13.64 | |||||
Inventory, 2 Yr. CAGR % | -7.85 | 6.24 | 37.75 | 25.72 | 6.42 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 17.87 | 0.34 | 15.65 | 13.93 | 17.29 | |||||
Total Assets, 2 Yr. CAGR % | 10.17 | 8.81 | 18.65 | 18.12 | 16.32 | |||||
Tangible Book Value, 2 Yr. CAGR % | 13.59 | -0.11 | 0.93 | 6.5 | -5.85 | |||||
Common Equity, 2 Yr. CAGR % | 12.27 | 6.32 | 18.05 | 19.63 | 13.79 | |||||
Cash From Operations, 2 Yr. CAGR % | 38.83 | 2.59 | -18.34 | -3.1 | 37.18 | |||||
Capital Expenditures, 2 Yr. CAGR % | -6.26 | 0.31 | 8.79 | 46.12 | 21.79 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 56.78 | -1.34 | -48.53 | -6.64 | 62.89 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 53.9 | -2.25 | -46.46 | -2.56 | 65.83 | |||||
Dividend Per Share, 2 Yr. CAGR % | 9.11 | 11.8 | 16.62 | 12.55 | 5.72 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 4.82 | 1.17 | 6.75 | 18.65 | 17.07 | |||||
Gross Profit, 3 Yr. CAGR % | 6.76 | 3.43 | 7.48 | 19.09 | 14.09 | |||||
EBITDA, 3 Yr. CAGR % | 6.83 | 3.8 | 9.25 | 19.86 | 12.57 | |||||
EBITA, 3 Yr. CAGR % | 7.82 | 4.68 | 10.42 | 21.07 | 12.2 | |||||
EBIT, 3 Yr. CAGR % | 7.86 | 4.53 | 9.96 | 20.04 | 10.82 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 7.97 | 9.14 | 12.65 | 20.47 | 7.39 | |||||
Net Income, 3 Yr. CAGR % | 7.9 | 9.13 | 12.65 | 20.43 | 7.35 | |||||
Normalized Net Income, 3 Yr. CAGR % | 7 | 6 | 10.59 | 18.71 | 7.57 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 8.11 | 9.16 | 12.43 | 20.35 | 7.37 | |||||
Accounts Receivable, 3 Yr. CAGR % | -2.72 | -4 | 9.34 | 20.21 | 19.71 | |||||
Inventory, 3 Yr. CAGR % | 1.9 | 4.09 | 17.27 | 28.04 | 17.4 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 13.88 | 16.54 | 5.74 | 13.93 | 17.33 | |||||
Total Assets, 3 Yr. CAGR % | 16.79 | 10.35 | 14.61 | 15.59 | 19.83 | |||||
Tangible Book Value, 3 Yr. CAGR % | 29.97 | 6.81 | 2.48 | 2.32 | -1.49 | |||||
Common Equity, 3 Yr. CAGR % | 25.31 | 11.03 | 13.2 | 15.83 | 18.45 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.21 | 20.72 | -8.38 | -5.01 | 11.2 | |||||
Capital Expenditures, 3 Yr. CAGR % | 6.14 | -5.37 | 7.28 | 27.22 | 22.09 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -5.4 | 16.5 | -26.27 | -17.59 | 2.56 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -5.44 | 15.17 | -24.84 | -15.12 | 6.51 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 12.62 | 12.31 | 14.98 | 8.2 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 4.73 | 7.9 | 9.64 | 9.53 | 9.26 | |||||
Gross Profit, 5 Yr. CAGR % | 6.08 | 11.17 | 11.05 | 10.63 | 8.42 | |||||
EBITDA, 5 Yr. CAGR % | 6.24 | 12.82 | 11.53 | 10.94 | 8.58 | |||||
EBITA, 5 Yr. CAGR % | 7.61 | 15.06 | 12.73 | 11.71 | 8.96 | |||||
EBIT, 5 Yr. CAGR % | 7.66 | 15.17 | 12.51 | 11.1 | 8.07 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 8.66 | 16.95 | 14.37 | 11.71 | 8.27 | |||||
Net Income, 5 Yr. CAGR % | 8.55 | 16.89 | 14.33 | 11.67 | 8.25 | |||||
Normalized Net Income, 5 Yr. CAGR % | 7.19 | 15.21 | 13.23 | 9.53 | 7.03 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 8.68 | 16.95 | 14.41 | 11.71 | 8.13 | |||||
Accounts Receivable, 5 Yr. CAGR % | 1.91 | 3.63 | 7.86 | 5.19 | 11.04 | |||||
Inventory, 5 Yr. CAGR % | 4.54 | 10.93 | 14.96 | 12.26 | 12.8 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 6.25 | 9.92 | 14.59 | 15.49 | 10.22 | |||||
Total Assets, 5 Yr. CAGR % | 9.08 | 10.13 | 17.53 | 13.39 | 15.29 | |||||
Tangible Book Value, 5 Yr. CAGR % | 10.71 | 7.93 | 17.46 | 6.69 | -0.94 | |||||
Common Equity, 5 Yr. CAGR % | 9.82 | 10.23 | 22.36 | 14.39 | 13.44 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.31 | 7.09 | 1.43 | 10.56 | 7.67 | |||||
Capital Expenditures, 5 Yr. CAGR % | 6.62 | 10.79 | 7.19 | 12.59 | 12.86 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 23.87 | -25.84 | 6.59 | 0.95 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 22.36 | -24.68 | 7.69 | 2.88 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 12.59 | 9.63 |
- Stock Market
- Equities
- EPI A Stock
- Financials Epiroc AB
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















